Unosi

• Kliničke vodilje za tretman HIV-a i AIDS-a u Bosni i Hercegovini (2016)

  A. Verhaz, S. Adžić, Z. Čardaklija, S. Hadžialjević, V. Hadžiosmanović, Z. Kezić, T. Kovačević, J. Medar-Petrović, D. Milaković, A. Novo, S. Skočibušić, S. Stojisavljević, S. Šabović, Kliničke vodilje za tretman HIV-a i AIDS-a u Bosni i Hercegovini, pp. 86 - 100, Udruženje "Partnerstvo za zdravlje", Sarajevo, 2016

• Liječenje oboljelih sa koinfekcijama: Hepatitis B i C i HIV.; Tuberkuloza i HIV (2016)

  A. Verhaz, Z. Čardaklija, S. Adžić, S. Hadžialjević, V. Hadžiosmanović, Z. Kezić, T. Kovačević, J. Medar-Petrović, D. Milaković, A. Novo, S. Skočibušić, S. Stojisavljević, S. Šabović, Liječenje oboljelih sa koinfekcijama: Hepatitis B i C i HIV.; Tuberkuloza i HIV, Kliničke vodilje za tretman HIV-a i AIDS-a u Bosni i Hercegovini, pp. 121 - 140, udruženje "Partnerstvo za zdravlje", Sarajevo, 2016

• Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation—A Step toward Correct Dosing (2024-02)

  D. Milaković, T. Kovačević, P. Kovačević, V. Barišić, S. Avram, S. Dragić, B. Zlojutro, D. Momčičević, B. Miljković, K. Vučićević, Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation—A Step toward Correct Dosing, PHARMACEUTICS, Vol. 16, No. 2, Feb, 2024

• Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study (2024-05)

  P. Kovačević, D. Milaković, T. Kovačević, V. Barišić, S. Dragić, B. Zlojutro, B. Miljković, K. Vučićević, Z. Rizwan, Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study, NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY, Vol. 397, pp. 7747 - 7756, May, 2024

• Medication Discrepancies in Patients After Transition of Care from Intensive Care Unit to Ward and At Hospital Discharge: A Pilot Study (2024-06)

  V. Barišić, T. Kovačević, P. Kovačević, S. Dragić, D. Milaković, D. Momčičević, B. Zlojutro, R. Škrbić, Medication Discrepancies in Patients After Transition of Care from Intensive Care Unit to Ward and At Hospital Discharge: A Pilot Study, LATIN AMERICAN JOURNAL OF PHARMACY, Vol. 43, No. 5, pp. 88 - 96, Jun, 2024

• Doziranje vankomicina i gentamicina kod kritično oboljelih u KC Banja Luka (2014)

  T. Kovačević, P. Kovačević, S. Avram, D. Milaković, N. Špirić, Doziranje vankomicina i gentamicina kod kritično oboljelih u KC Banja Luka, ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, pp. 75 - 81, 2014

• Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients (2016)

  T. Kovačević, P. Kovačević, A. Sanja, D. Milaković, N. Špirić, Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients, Journal of Basic and Clinical Pharmacy, Vol. 7, No. 3, pp. 65 - 69, 2016

• Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)

  W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. Chalouhi El-Khouri, F. Irazoque-Palazuelos, F. Fidencio Cons Molina, P. Shesternya, P. Miranda, F. G. Medina-Rodriguez, P. Wiland, S. Jeka, J. Chavez-Corrales, O. Garmish, T. Linde, D. Rekalov, P. Hrycaj, A. Krause, N. Fomina, O. Piura, M. Abello-Banfi, C. Hee Suh, S. Cheol Shim, S. Joon Lee, S. Young Lee, S. Hwan Kim, D. Hyun Yoo, Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, pp. 100 - 101, Sep, 2016

• Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial (2018-08)

  W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. El-Khouri, F. Irazoque-Palazuelos, F. Molina, P. Shesternya, P. Miranda, F. Medina-Rodriguez, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, pp. 934 - 943, Aug, 2018

• Variation of the Radiochemical Purity of 99mTc-Sestamibi Reconstituted by Different Generator's Eluates. (2014)

  A. Stanković, Z. Rajkovača, D. Milaković, G. Vuleta, Variation of the Radiochemical Purity of 99mTc-Sestamibi Reconstituted by Different Generator's Eluates., Eur J Nucl Med Mol Imaging, 2014

• 99mTc-colloidal rhenium sulphide influence of different generators eluates on fluctuations in radiochemical purity (2015)

  A. Stanković, D. Milaković, Z. Rajkovača, 99mTc-colloidal rhenium sulphide influence of different generators eluates on fluctuations in radiochemical purity, World Journal of Nuclear Medicine, 2015

• 99mTc Colloid Rhenium Sulphide: Influence of different generator’s eluates on fluctuations in radiochemical purity, (2015)

  A. Stanković, Z. Rajkovača, D. Milaković, 99mTc Colloid Rhenium Sulphide: Influence of different generator’s eluates on fluctuations in radiochemical purity,, World J Nucl Med, pp. 100 - 101, 2015